Laronde

Laronde is owned by Flagship Pioneering.

Flagship Pioneering has 5 subsidiaries including Alltrna, Laronde and Pioneering Medicines.

They are in:

• Biotechnology83%
• Fund17%

View the org chart displaying its 10 main executives

Most searched biographies at Laronde

• Pablo Cagnoni, Director
• John Mendlein, Interim Chief Executive Officer and Chairman of the...
• Sheri McCoy, Director

Popular executive movements at Laronde

• John Mendlein who is Chairman of the Board, will be promoted to Interim Chief Executive Officer and Chairman of the Board on May 26, 2023  (posted on May 9 2023).
• Trevor Hallam will join the company as Chief Scientific Officer on May 15, 2023  (posted on May 9 2023).
• Pablo Cagnoni who is Chief Executive Officer and Director, will become Director on May 26, 2023  (posted on May 9 2023).

Popular executive movements at Flagship Pioneering

• Amanda Kay, who was Operating Partner and President of Metaphore Biotechnologies, is promoted to Senior Partner and Chief Business Development Officer  (posted on September 12 2023).
• Jason Gardner has joined the company as Director, Chief Executive Officer-Parter and Chief Executive Officer of Ampersand Biomedicines  (posted on August 15 2023).
• Rupert Vessey will join the company as Chief Scientist and Executive Partner on Jul. 31, 2023  (posted on July 18 2023).

Create your alert
to follow the executive moves at Laronde.

Flagship Pioneering has 2,205 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Biogen (United States (USA)).

Popular M&A news in Biotechnology

• Applied Molecular Transport and Cyclo Therapeutics have announced they will merge  (posted on September 22 2023)..
• Magnet Biomedicine has just announced a $50 Million fundraising (posted on September 21 2023).
• Cellectar has just announced a $103 Million fundraising (posted on September 19 2023).

Popular contacts in Biotechnology

• Shankar Ramaswamy - Chief Executive Officer and Chairman of the Board at Kriya Therapeutics
• Neal Mohan - Director at 23andMe
• Marc Dunoyer - Independent Director at Orchard Therapeutics

Learn more about the Biotechnology industry >

Press releases by Laronde

• Laronde Announces New Leadership
• Laronde to Present at the RNA Leaders Europe Congress
• Laronde Appoints Pablo J. Cagnoni as Chief Executive Officer
• Laronde Appoints John Mendlein as Chief Executive Officer
• Laronde Expands Board of Directors with Leading Pharmaceutical Executives
• Laronde Attracts $440M in First External Financing to Further Advance Endless RNA™ Platform
• Flagship Pioneering Unveils Laronde to Advance Endless RNA™ - A New Class of Programmable Medicines Capable of Expressing Therapeutic Proteins Inside the Body
• View more press releases Close

Social media about Laronde

• Laronde on Wikipedia, Google News & Yahoo Finance
• Laronde on LinkedIn, Twitter & YouTube

Contact by email its executives including Tej Pavoor

Call Laronde at +1 617...

View the org chart

Register to receive your alert

Report an error